Home » today » Technology » Rich countries have “luxuriated” vaccines. Pfizer promised: We will deliver 40 million doses to the poor

Rich countries have “luxuriated” vaccines. Pfizer promised: We will deliver 40 million doses to the poor

Pfizer has now committed to delivering up to 40 million doses of its vaccine to a special WHO program called COVAX this year. It is intended for poor and medium-rich countries, which would otherwise only have great difficulty in supplying covid vaccines. The promise was announced at a virtual conference on Friday and is considered a strengthening of the COVAX program. In his emotional speech from last week, Tedros indicated, among other things, the possibility of the collapse of this program, if the approach of rich states and companies does not change.

Forty million doses from Pfizer is just a small snippet in the amount that will be needed. The goal of the COVAX program is to inoculate over a billion people in 92 poor or medium-rich countries. Following Pfizer’s promise, Tedros said that if the promised deliveries from AstraZenec (150 million doses) were fulfilled, COVAX could start in February. According to the AP agency, he also expressed optimism about the fulfillment of the programme’s goals. By the end of the year, he said, he should redistribute more than two billion doses to the poorest corners of the planet.

Fair access to vaccines

Pfizer was the only company that undertook last year when developing the vaccine to supply its products to poor countries only at cost. Now, however, he and the German company BioNTech have stated that they will supply the vaccine for COVAX at a non-profit price. However, they did not disclose its amount. They also promised to help poor countries with logistics, because their product requires a storage temperature of minus 70 degrees Celsius. ”

Somalia, for example, does not have the technology to maintain such a low temperature. “In our strength, the temperature would be around minus ten,” said Abdirizak Yusuf Hirabeh, the government’s agent for the fight against the covid.

Seth Berkley, CEO of GAVI The Vaccine Alliance, which leads the purchase and supply of vaccines for COVAX, described the agreement as “a significant step forward in terms of equitable access to vaccines.”

The U.S. pharmaceutical company, despite the difficulties it has had in delivering days in recent days, also announced on Friday that it is increasing its production and expects to be able to produce two billion batches in 2021, up from its previous forecast of 1.3 billion batches. This increase is also said to be behind the production problems of the Belgian factory. According to the company, it has slowed down because it is currently undergoing technological changes that will allow the announced increase in production.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.